Sexual & Reproductive Health
Angiogenic growth factors may attenuate erectile dysfunction in the rat penis
Published in Gene Therapy Weekly, November 24th, 2005
Scientists in the United States conducted research "to establish a laboratory animal model for vascular endothelial growth factor (VEGF) transfer in the rat penis to invent a curative therapy for ED. Vascular insufficiency is a common pathomechanism of ED."
"Previous investigations have shown neovascularization of ischemic organs after gene transfer of VEGF. For VEGF-protein transfer, osmotic pumps were connected to the renal arteries of rats. The pumps were filled with human VEGF165 protein (n=20) or sterile saline (n=20). After 28 days, a VEGF serum...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-11-24)
More Articles from Gene Therapy Weekly
- Immunotherapy
University of Manchester scientists receive grant to study T cell-mediated immunotherapy - Oncology
Small interfering RNA halts lymphangiogenesis and metastasis - Angiology
Gene transfer stimulates neoangiogenesis in rabbit peripheral ischemia models - Apoptosis
Full-length p73 alpha repressed drug-induced apoptosis in lung carcinoma cells - Awards
Biocompatible stent coatings company wins 2005 technology innovation award - DNA Research
Anticancer agent EZZ induces cell cycle arrest in S phase by inhibiting DNA replication - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
